메뉴 건너뛰기




Volumn 34, Issue 1, 2013, Pages 93-98

Serum carnitine levels and levocarnitine supplementation in institutionalized Huntington's disease patients

Author keywords

Carnitine; Catabolism; Huntington's disease; Levocarnitine; Valproic acid

Indexed keywords

CARNITINE;

EID: 84872675239     PISSN: 15901874     EISSN: 15903478     Source Type: Journal    
DOI: 10.1007/s10072-012-0952-x     Document Type: Article
Times cited : (14)

References (37)
  • 1
    • 0032877586 scopus 로고    scopus 로고
    • NMDA and non-NMDA receptor-mediated excitotoxicity are potentiated in cultured striatal neurons by prior chronic depolarization
    • 10486197 10.1006/exnr.1999.7135 1:CAS:528:DyaK1MXlvVWqs78%3D
    • Chen Q, Surmeier DJ, Reiner A (1999) NMDA and non-NMDA receptor-mediated excitotoxicity are potentiated in cultured striatal neurons by prior chronic depolarization. Exp Neurol 159:283-296
    • (1999) Exp Neurol , vol.159 , pp. 283-296
    • Chen, Q.1    Surmeier, D.J.2    Reiner, A.3
  • 2
    • 29244479196 scopus 로고    scopus 로고
    • Proteomic analysis of protein expression and oxidative modification in r6/2 transgenic mice: A model of Huntington disease
    • 15968004 10.1074/mcp.M500090-MCP200 1:CAS:528:DC%2BD2MXhtlWqsb7N
    • Perluigi M, Poon HF, Maragos W, Pierce WM, Klein JB, Calabrese V, Cini C, De Marco C, Butterfield DA (2005) Proteomic analysis of protein expression and oxidative modification in r6/2 transgenic mice: a model of Huntington disease. Mol Cell Proteomics 4:1849-1861
    • (2005) Mol Cell Proteomics , vol.4 , pp. 1849-1861
    • Perluigi, M.1    Poon, H.F.2    Maragos, W.3    Pierce, W.M.4    Klein, J.B.5    Calabrese, V.6    Cini, C.7    De Marco, C.8    Butterfield, D.A.9
  • 3
    • 37749000434 scopus 로고    scopus 로고
    • Oxidative stress parameters in plasma of Huntington's disease patients, asymptomatic Huntington's disease gene carriers and healthy subjects: A cross-sectional study
    • 17990062 10.1007/s00415-007-0611-y 1:CAS:528:DC%2BD1cXhvVCmtb8%3D
    • Klepac N, Relja M, Klepac R, Hećimović S, Babić T, Trkulja V (2007) Oxidative stress parameters in plasma of Huntington's disease patients, asymptomatic Huntington's disease gene carriers and healthy subjects: a cross-sectional study. J Neurol 254:1676-1683
    • (2007) J Neurol , vol.254 , pp. 1676-1683
    • Klepac, N.1    Relja, M.2    Klepac, R.3    Hećimović, S.4    Babić, T.5    Trkulja, V.6
  • 5
    • 0026794813 scopus 로고
    • Cellular localization of a metabotropic glutamate receptor in rat brain
    • 1323311 10.1016/0896-6273(92)90165-A 1:CAS:528:DyaK38XlvVGgs7k%3D
    • Martin LJ, Blackstone CD, Huganir RL, Price DL (1992) Cellular localization of a metabotropic glutamate receptor in rat brain. Neuron 9:259-270
    • (1992) Neuron , vol.9 , pp. 259-270
    • Martin, L.J.1    Blackstone, C.D.2    Huganir, R.L.3    Price, D.L.4
  • 6
    • 0035960544 scopus 로고    scopus 로고
    • Coenzyme Q10 and remacemide hydrochloride ameliorate motor deficits in a Huntington's disease transgenic mouse model
    • 11716985 10.1016/S0304-3940(01)02326-6 1:CAS:528:DC%2BD3MXosFKqs7k%3D
    • Schilling G, Coonfield ML, Ross CA, Borchelt DR (2001) Coenzyme Q10 and remacemide hydrochloride ameliorate motor deficits in a Huntington's disease transgenic mouse model. Neurosci Lett 315:149-153
    • (2001) Neurosci Lett , vol.315 , pp. 149-153
    • Schilling, G.1    Coonfield, M.L.2    Ross, C.A.3    Borchelt, D.R.4
  • 7
    • 10644229056 scopus 로고    scopus 로고
    • Kinetics, pharmacokinetics, and regulation of l-carnitine and acetyl-l-carnitine metabolism
    • 15591001 10.1196/annals.1320.003 1:CAS:528:DC%2BD2MXjvFOhug%3D%3D
    • Rebouche CJ (2004) Kinetics, pharmacokinetics, and regulation of l-carnitine and acetyl-l-carnitine metabolism. Ann N Y Acad Sci 1033:30-41
    • (2004) Ann N y Acad Sci , vol.1033 , pp. 30-41
    • Rebouche, C.J.1
  • 8
    • 0012738864 scopus 로고    scopus 로고
    • Pharmacokinetics of l-carnitine
    • 12908852 10.2165/00003088-200342110-00002 1:CAS:528:DC%2BD3sXnslGms74%3D
    • Evans AM, Fornasini G (2003) Pharmacokinetics of l-carnitine. Clin Pharmacokinet 42:941-967
    • (2003) Clin Pharmacokinet , vol.42 , pp. 941-967
    • Evans, A.M.1    Fornasini, G.2
  • 9
    • 70449707694 scopus 로고    scopus 로고
    • Effect of l-carnitine on the size of low-density lipoprotein particles in type 2 diabetes mellitus patients treated with simvastatin
    • 19604523 10.1016/j.metabol.2009.05.014 1:CAS:528:DC%2BD1MXht1OnsrjO
    • Malaguarnera M, Vacante M, Motta M, Malaguarnera M, Volti GL, Galvano F (2009) Effect of l-carnitine on the size of low-density lipoprotein particles in type 2 diabetes mellitus patients treated with simvastatin. Metabolism 58:1618-1623
    • (2009) Metabolism , vol.58 , pp. 1618-1623
    • Malaguarnera, M.1    Vacante, M.2    Motta, M.3    Malaguarnera, M.4    Volti, G.L.5    Galvano, F.6
  • 10
    • 58149379405 scopus 로고    scopus 로고
    • L-Carnitine supplementation reduces oxidized LDL cholesterol in patients with diabetes
    • 19056606 10.3945/ajcn.2008.26251 1:CAS:528:DC%2BD1MXnsFKgsw%3D%3D
    • Malaguarnera M, Vacante M, Avitabile T, Malaguarnera M, Cammalleri L, Motta M (2009) l-Carnitine supplementation reduces oxidized LDL cholesterol in patients with diabetes. Am J Clin Nutr 89:71-76
    • (2009) Am J Clin Nutr , vol.89 , pp. 71-76
    • Malaguarnera, M.1    Vacante, M.2    Avitabile, T.3    Malaguarnera, M.4    Cammalleri, L.5    Motta, M.6
  • 11
    • 68149181537 scopus 로고    scopus 로고
    • Effects of simvastatin and carnitine versus simvastatin on lipoprotein(a) and apoprotein(a) in type 2 diabetes mellitus
    • 10.1517/14656560903081745
    • Galvano F, Volti GL, Malaguarnera M, Avitabile T, Antic T, Vacante M, Malaguarnera M (2006) Effects of simvastatin and carnitine versus simvastatin on lipoprotein(a) and apoprotein(a) in type 2 diabetes mellitus. Expert Opin Pharmacother 10:1875-1882
    • (2006) Expert Opin Pharmacother , vol.10 , pp. 1875-1882
    • Galvano, F.1    Volti, G.L.2    Malaguarnera, M.3    Avitabile, T.4    Antic, T.5    Vacante, M.6    Malaguarnera, M.7
  • 12
    • 0034769470 scopus 로고    scopus 로고
    • Carnitine as a free radical scavenger in aging
    • Rani PJA, Panneerselvam C (2001) Carnitine as a free radical scavenger in aging. Exp Gerontol 6:1713-1726
    • (2001) Exp Gerontol , vol.6 , pp. 1713-1726
    • Rani, P.J.A.1    Panneerselvam, C.2
  • 13
    • 0028608835 scopus 로고
    • Protective effect of carnitine on lipoperoxide formation in rat brain
    • 7794887
    • Koudelová J, Mourek J, Drahota Z, Rauchová H (1994) Protective effect of carnitine on lipoperoxide formation in rat brain. Physiol Res 43:387-389
    • (1994) Physiol Res , vol.43 , pp. 387-389
    • Koudelová, J.1    Mourek, J.2    Drahota, Z.3    Rauchová, H.4
  • 14
    • 36849090508 scopus 로고    scopus 로고
    • L-Carnitine treatment reduces severity of physical and mental fatigue and increases cognitive functions in centenarians: A randomized and controlled clinical trial
    • 18065594 1:CAS:528:DC%2BD2sXhsVGhsL%2FI
    • Malaguarnera M, Cammalleri L, Gargante MP, Vacante M, Colonna V, Motta M (2007) l-Carnitine treatment reduces severity of physical and mental fatigue and increases cognitive functions in centenarians: a randomized and controlled clinical trial. Am J Clin Nutr 86:1738-1744
    • (2007) Am J Clin Nutr , vol.86 , pp. 1738-1744
    • Malaguarnera, M.1    Cammalleri, L.2    Gargante, M.P.3    Vacante, M.4    Colonna, V.5    Motta, M.6
  • 15
    • 83655192001 scopus 로고    scopus 로고
    • Acetyl-l-carnitine improves cognitive functions in severe hepatic encephalopathy: A randomized and controlled clinical trial
    • 21870121 10.1007/s11011-011-9260-z 1:CAS:528:DC%2BC3MXhsVeltb7I
    • Malaguarnera M, Vacante M, Motta M, Giordano M, Malaguarnera G, Bella R, Nunnari G, Rampello L, Pennisi G (2011) Acetyl-l-carnitine improves cognitive functions in severe hepatic encephalopathy: a randomized and controlled clinical trial. Metab Brain Dis 26:281-289
    • (2011) Metab Brain Dis , vol.26 , pp. 281-289
    • Malaguarnera, M.1    Vacante, M.2    Motta, M.3    Giordano, M.4    Malaguarnera, G.5    Bella, R.6    Nunnari, G.7    Rampello, L.8    Pennisi, G.9
  • 17
    • 33846989018 scopus 로고    scopus 로고
    • Effects of l-acetylcarnitine on cirrhotic patients with hepatic coma: Randomized double-blind, placebo-controlled trial
    • 17080254 10.1007/s10620-006-9187-0 1:CAS:528:DC%2BD2sXktFCksg%3D%3D
    • Malaguarnera M, Pistone G, Astuto M, Vecchio I, Raffaele R, Lo Giudice E, Rampello L (2006) Effects of l-acetylcarnitine on cirrhotic patients with hepatic coma: randomized double-blind, placebo-controlled trial. Dig Dis Sci 51:2242-2247
    • (2006) Dig Dis Sci , vol.51 , pp. 2242-2247
    • Malaguarnera, M.1    Pistone, G.2    Astuto, M.3    Vecchio, I.4    Raffaele, R.5    Lo Giudice, E.6    Rampello, L.7
  • 19
    • 84855267416 scopus 로고    scopus 로고
    • Levocarnitine for valproic-acid-induced hyperammonemic encephalopathy
    • 22180549 10.2146/ajhp110049 1:CAS:528:DC%2BC38XotFKht7s%3D
    • Mock CM, Schwetschenau KH (2012) Levocarnitine for valproic-acid-induced hyperammonemic encephalopathy. Am J Health Syst Pharm 69:35-39
    • (2012) Am J Health Syst Pharm , vol.69 , pp. 35-39
    • Mock, C.M.1    Schwetschenau, K.H.2
  • 20
    • 77952322688 scopus 로고    scopus 로고
    • Neuroprotective effects of l-carnitine in a transgenic animal model of Huntington's disease
    • 19932584 10.1016/j.biopha.2009.06.020 1:CAS:528:DC%2BC3cXltFykurY%3D
    • Vamos E, Voros K, Vecsei L, Klivenyi P (2010) Neuroprotective effects of l-carnitine in a transgenic animal model of Huntington's disease. Biomed Pharmacother 64:282-286
    • (2010) Biomed Pharmacother , vol.64 , pp. 282-286
    • Vamos, E.1    Voros, K.2    Vecsei, L.3    Klivenyi, P.4
  • 21
    • 0016823810 scopus 로고
    • Mini-Mental State" a practical method for grading the cognitive state of patients for the clinician
    • 1202204 10.1016/0022-3956(75)90026-6 1:STN:280:DyaE28%2FntFKjtw%3D%3D
    • Folstein M, Folstein SE, McHugh PR (1975) "Mini-Mental State" a practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 12:189-198
    • (1975) J Psychiatr Res , vol.12 , pp. 189-198
    • Folstein, M.1    Folstein, S.E.2    McHugh, P.R.3
  • 22
    • 85009332113 scopus 로고    scopus 로고
    • Unified Huntington's Disease Rating Scale: Reliability and consistency
    • Huntington Study Group 10.1002/mds.870110204
    • Huntington Study Group (1996) Unified Huntington's Disease Rating Scale: reliability and consistency. Mov Disord 11:136-142
    • (1996) Mov Disord , vol.11 , pp. 136-142
  • 23
    • 0030239661 scopus 로고    scopus 로고
    • Summary of WIC nutrition risk criteria: A scientific assessment. Committee on Scientific Evaluation of WIC Nutrition Risk Criteria Food and Nutrition Board, Institute of Medicine
    • National Academy of Sciences 10.1016/S0002-8223(96)00257-X
    • National Academy of Sciences (1996) Summary of WIC nutrition risk criteria: a scientific assessment. Committee on Scientific Evaluation of WIC Nutrition Risk Criteria Food and Nutrition Board, Institute of Medicine. J Am Diet Assoc 96:925-930
    • (1996) J Am Diet Assoc , vol.96 , pp. 925-930
  • 24
    • 79551595148 scopus 로고    scopus 로고
    • Clinical correlates of low serum carnitine levels in hospitalized psychiatric patients
    • 20586533 10.3109/15622975.2010.489619
    • Cuturic M, Abramson RK, Moran RR, Hardin JW, Hall AV (2011) Clinical correlates of low serum carnitine levels in hospitalized psychiatric patients. World J Biol Psychiatry 12(1):73-79
    • (2011) World J Biol Psychiatry , vol.12 , Issue.1 , pp. 73-79
    • Cuturic, M.1    Abramson, R.K.2    Moran, R.R.3    Hardin, J.W.4    Hall, A.V.5
  • 25
    • 76849090445 scopus 로고    scopus 로고
    • Clinical outcomes and low-dose levocarnitine supplementation in psychiatric inpatients with documented hypocarnitinemia: A retrospective chart review
    • 20098226 10.1097/01.pra.0000367773.03636.d1
    • Cuturic M, Abramson RK, Moran RR, Hardin JW (2010) Clinical outcomes and low-dose levocarnitine supplementation in psychiatric inpatients with documented hypocarnitinemia: a retrospective chart review. J Psychiatr Pract 16:5-14
    • (2010) J Psychiatr Pract , vol.16 , pp. 5-14
    • Cuturic, M.1    Abramson, R.K.2    Moran, R.R.3    Hardin, J.W.4
  • 26
    • 33646518622 scopus 로고    scopus 로고
    • Disorders of carnitine transport and the carnitine cycle
    • 16602102 10.1002/ajmg.c.30087 1:CAS:528:DC%2BD2sXms1WisL4%3D
    • Longo N, di San Amat, Filippo C, Pasquali M (2006) Disorders of carnitine transport and the carnitine cycle. Am J Med Genet C Semin Med Genet 142C:77-85
    • (2006) Am J Med Genet C Semin Med Genet , vol.142 , pp. 77-85
    • Longo, N.1    Di San, A.2    Filippo, C.3    Pasquali, M.4
  • 27
    • 0030732758 scopus 로고    scopus 로고
    • Acquired carnitine abnormalities in critically ill children
    • 9392402 10.1007/s004310050732 1:CAS:528:DyaK2sXnt1CgtLs%3D
    • Proulx F, Lacroix J, Qureshi IA, Nadeau D, Gauthier M, Lambert M (1997) Acquired carnitine abnormalities in critically ill children. Eur J Pediatr 156:864-869
    • (1997) Eur J Pediatr , vol.156 , pp. 864-869
    • Proulx, F.1    Lacroix, J.2    Qureshi, I.A.3    Nadeau, D.4    Gauthier, M.5    Lambert, M.6
  • 29
    • 33646162644 scopus 로고    scopus 로고
    • Plasma free carnitine in epilepsy children, adolescents and young adults treated with old and new antiepileptic drugs with or without ketogenic diet
    • 16376041 10.1016/j.braindev.2005.11.005
    • Coppola G, Epifanio G, Auricchio G, Federico RR, Resicato G, Pascotto A (2006) Plasma free carnitine in epilepsy children, adolescents and young adults treated with old and new antiepileptic drugs with or without ketogenic diet. Brain Dev 28:358-365
    • (2006) Brain Dev , vol.28 , pp. 358-365
    • Coppola, G.1    Epifanio, G.2    Auricchio, G.3    Federico, R.R.4    Resicato, G.5    Pascotto, A.6
  • 30
    • 0033965329 scopus 로고    scopus 로고
    • Higher sedentary energy expenditure in patients with Huntington's disease
    • 10632102 10.1002/1531-8249(200001)47:1<64: AID-ANA11>3.0.CO;2-S 1:STN:280:DC%2BD3c%2FpsF2lsQ%3D%3D
    • Pratley RE, Salbe AD, Ravussin E, Caviness JN (2000) Higher sedentary energy expenditure in patients with Huntington's disease. Ann Neurol 47:64-70
    • (2000) Ann Neurol , vol.47 , pp. 64-70
    • Pratley, R.E.1    Salbe, A.D.2    Ravussin, E.3    Caviness, J.N.4
  • 31
    • 0025101871 scopus 로고
    • Carnitine deficiency syndromes
    • 2187442 10.1016/0887-8994(90)90037-2 1:STN:280:DyaK3c3ltlCrtA%3D%3D
    • Breningstall GN (1990) Carnitine deficiency syndromes. Pediatr Neurol 6:75-81
    • (1990) Pediatr Neurol , vol.6 , pp. 75-81
    • Breningstall, G.N.1
  • 32
    • 27144539588 scopus 로고    scopus 로고
    • Science review: Carnitine in the treatment of valproic acid-induced toxicity - What is the evidence?
    • 16277730 10.1186/cc3742
    • Lheureux PE, Penaloza A, Zahir S et al (2005) Science review: carnitine in the treatment of valproic acid-induced toxicity - what is the evidence? Crit Care 9:431-440
    • (2005) Crit Care , vol.9 , pp. 431-440
    • Lheureux, P.E.1    Penaloza, A.2    Zahir, S.3
  • 33
    • 0028850504 scopus 로고
    • Primary and secondary carnitine deficiency syndromes
    • Pons R, De Vivo DC (1995) Primary and secondary carnitine deficiency syndromes. J Child Neurol 10(suppl. 2):8-24
    • (1995) J Child Neurol , vol.10 , Issue.SUPPL. 2 , pp. 8-24
    • Pons, R.1    De Vivo, D.C.2
  • 35
    • 0025050646 scopus 로고
    • L-Acetyl-carnitine in Huntington's disease: Double-blind placebo controlled crossover study of drug effects on movement disorder and dementia
    • 2143808 10.1002/mds.870050317 1:STN:280:DyaK3czls1SntA%3D%3D
    • Goety CG, Tanner CM, Cohen JA, Thelen JA, Carroll VS, Klawans HL, Fariello RG (1990) l-Acetyl-carnitine in Huntington's disease: double-blind placebo controlled crossover study of drug effects on movement disorder and dementia. Mov Disord 5:263-265
    • (1990) Mov Disord , vol.5 , pp. 263-265
    • Goety, C.G.1    Tanner, C.M.2    Cohen, J.A.3    Thelen, J.A.4    Carroll, V.S.5    Klawans, H.L.6    Fariello, R.G.7
  • 36
    • 15244352953 scopus 로고    scopus 로고
    • Free and total carnitine concentrations in pig plasma after oral ingestion of various l-carnitine compounds
    • 15830915 10.1024/0300-9831.75.1.3 1:CAS:528:DC%2BD2MXivFCqtrk%3D
    • Eder K, Felgner J, Becker K et al (2005) Free and total carnitine concentrations in pig plasma after oral ingestion of various l-carnitine compounds. Int J Vitam Nutr Res 75:3-9
    • (2005) Int J Vitam Nutr Res , vol.75 , pp. 3-9
    • Eder, K.1    Felgner, J.2    Becker, K.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.